Renzo Cecere, MD
Heart failure
heart assist devices
mitral valve
stem cells
medical device design
CHAL Researchers banner
CHAL Researchers
The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.
Centre for Translational Biology (CTB)
Centre for Innovative Medicine (CIM)
Centre for Outcomes Research and Evaluation (CORE)
Subheading - Centre for Translational Biology (CTB)
Centre for Translational Biology (CTB)
Asset Publisher
 | |
| | Stella Daskalopoulou, MD, M.Sc., DIC, PhDatherosclerosis vascular biology arterial stiffness and vessel hemodynamics hypertension cardiovascular risk factors |
| | James Engert, PhDgenetic association studies single-nucleotide polymorphisms (SNPs) gene-environment interactions atherosclerosis aortic stenosis |
 | Jacques Genest, MDlipoproteins high-density lipoprotein (HDL) familial hypercholesterolemia genetics ABCA1 |
| | Robert Kiss, PhDcholesterol intracellular trafficking cell biology microscopy |
| | Adel Schwertani, PhDCardiology heart vasoactive substances atherosclerosis pulmonary hypertension |
Subheading - Centre for Innovative Medicine (CIM)
Centre for Innovative Medicine (CIM)
Asset Publisher
 | Dominic Chalut, MDasthma toxicology quality assurance trauma pediatric emergency medicine |
 | Robert Côté, MDstroke stroke prevention acute management clinical research |
| | Vidal Essebag, MD, PhDEpidemiology statistical analysis methodology database analysis data management |
 | Matthias Friedrich, MD, FESC, FACCCardiovascular magnetic resonance myocardial ischemia coronary heart disease acute myocardial infarction myocarditis |
 | Nadia Giannetti, MDDéfaillance cardiaque greffe cardiaque cardiomyopathie heart transplantation |
| | Ronald Gottesman, MDSimulation medical education clinical trials expert systems |
 | Thao Huynh, MDcardiovascular sex and gender ethnicity knowledge translation guidelines |
 | Kevin Lachapelle, MDMarrow stromal cells angiogenesis revascularization |
 | Ilka Lowensteyn, PhDCardiac rehabilitation exercise physiology kinesiology prevention wellness |
| | Sheldon Magder, MDVascular biology endothelial function nitric oxide estrogen oxygen radicals |
 | David Mulder, MDGeneral thoracic surgery lung cancer thoracic trauma airway injury sports medicine |
| | Nicolo Piazza, MD, PhD, FRCO(C), FESCAortic Valve mitral Valve transcatheter valves transcatheter aortic valve implantation transcatheter aortic valve replacement |
 | Sam Shemie, MDBrain death neurological determination of death organ donation organ donor management pediatric |
| | Dominique Shum-Tim, MD, M.Sc.Pediatric cardiac surgery cardiopulmonary bypass hypothermia circulatory arrest systemic inflammatory response |
| | Susan Solymoss, MDthrombosis anticoagulation treatment prevention hemostasis |
| | Oren Steinmetz, MDaneurysm carotid stenosis endovascular |
Subheading - Centre for Outcomes Research and Evaluation (CORE)
Centre for Outcomes Research and Evaluation (CORE)
Asset Publisher
| | Michal Abrahamowicz, PhDbiostatistics cohort studies comparative effectiveness confounding instrumental variables |
| | James Brophy, MD, PhDCardiovascular epidemiology medical decision making. |
 | Natalie Dayan, MD, M.Sc., FRCPCepidemiology vascular perinatal women's health |
| | Mark Goldberg, BSc, MSc, PhDepidemiology environment occupation cancer cardiorespiratory diseases |
 | Ariane Marelli, MD, MPH, FRCPC, FACC, FAHAhealth services epidemiology congenital heart disease cardiovascular cardiology |
 | Louise Pilote, MD, MPH, PhDpharmacoepidemiology comparative effectivenesse sex differences in cardiovascular diseases outcomes research cardiovascular epidemiology |
| | Allan Sniderman, MDPrevention cardiovascular disease atherosclerosis apoB |
 | Robyn Tamblyn, MScN, M.Sc., PhD, CMHealth services medical education medical informatics practice changes pharmacoepidemiology |
 | George Thanassoulis, MDGenetics genomics cardiovascular disease aortic stenosis myocardial infarction |